Jefferies backs Lupin, Zydus, and Biocon amid shifting US pharma market shares. Discover why these stocks are set to shine.

Fintel reports that on March 3, 2025, Jefferies downgraded their outlook for Sempra (NYSE:SRE) from Buy to Hold. Analyst ...

In a report released yesterday, Suneet Kamath from Jefferies maintained a Buy rating on Unum Group (UNM – Research Report), with a price target ...

In a report released yesterday, Mike Prew from Jefferies reiterated a Hold rating on Land Securities Group plc REIT (LAND – Research Report), ...

Jefferies Financial Group reaffirmed their buy rating on shares of Primary Health Properties (LON:PHP – Free Report) in a research note issued to investors on Monday,Digital Look reports. Jefferies ...

We recently published a list of 10 AI Stocks Poised for Big Moves. In this article, we are going to take a look at where ...

Adani Wilmar's volume has grown by 8% CAGR over financial years 2015-25, led by market share gains in foods and FMCG segment, ...

Vertex (NASDAQ:VERX – Free Report) had its target price trimmed by Jefferies Financial Group from $62.00 to $48.00 in a ...

Jefferies Group Inc. (Symbol: JEF) presently has an above average rank, in the top 50% of the coverage universe, which suggests it is among the top most "interesting" ideas that merit further ...

Polycab India shares surged nearly 5% on the BSE, defying fears from Ultratech’s entry into the C&W segment. Experts from ...